UBS Raises Numbers on CVS Caremark (CVS); Comments From Conference Call
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $77.92 -0.98%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
UBS maintains a 'Buy' on CVS Caremark (NYSE: CVS) price target raised from $49 to $53.
Analyst, Steven Valiquette, said, "It remains quite interesting to us the extent to which the mgmt of CVS is trying to keep investor expectations in check in relation to upside from the Walgreen (NYSE: WAG) / Express Scripts (Nasdaq: ESRX) impasse, but our sense is a growing portion of this former WAG customer base is now likely more inclined to stay with CVS such that we raise our 2013 EPS estimate from $3.70 to $3.75 to reflect an extended retail benefit from the impasse." (UBS raises FY12 EPS estimate from $3.26 to $3.33)
"Shares of CVS appear poised to move higher near-term if there is no WAG/ESRX resolution. We believe there may be resolution over the next month or two, which could cause a temporary dip in CVS."
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $45.92 yesterday.
Analyst, Steven Valiquette, said, "It remains quite interesting to us the extent to which the mgmt of CVS is trying to keep investor expectations in check in relation to upside from the Walgreen (NYSE: WAG) / Express Scripts (Nasdaq: ESRX) impasse, but our sense is a growing portion of this former WAG customer base is now likely more inclined to stay with CVS such that we raise our 2013 EPS estimate from $3.70 to $3.75 to reflect an extended retail benefit from the impasse." (UBS raises FY12 EPS estimate from $3.26 to $3.33)
"Shares of CVS appear poised to move higher near-term if there is no WAG/ESRX resolution. We believe there may be resolution over the next month or two, which could cause a temporary dip in CVS."
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $45.92 yesterday.
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
